Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 292,735 | 305,048 | 286,203 | 279,058 | 264,811 |
| Receivables | 160,467 | 168,641 | 179,919 | 158,038 | 151,568 |
| Inventories | 156,007 | 145,400 | 141,134 | 133,427 | 145,987 |
| Income taxes - deferred | 33,258 | 33,789 | 32,005 | 33,226 | 27,304 |
| Other current assets | 60,154 | 48,829 | 43,905 | 48,957 | 35,553 |
| TOTAL | $702,621 | $701,707 | $683,166 | $652,706 | $625,223 |
| Non-Current Assets | |||||
| PPE Net | 291,701 | 286,712 | 282,226 | 281,214 | 274,158 |
| Intangibles | 235,747 | 237,169 | 237,747 | 239,365 | 61,387 |
| Other Non-Current Assets | 60,563 | 57,605 | 59,185 | 57,231 | 234,470 |
| TOTAL | $588,011 | $581,486 | $579,158 | $577,810 | $570,015 |
| Total Assets | $1,290,632 | $1,283,193 | $1,262,324 | $1,230,516 | $1,195,238 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,050 | 1,035 | 1,019 |
| Accounts payable and accrued liabilities | 58,255 | 41,425 | 42,794 | 29,941 | 38,131 |
| Accrued Expenses | 167,449 | 147,245 | 134,519 | 148,919 | 134,161 |
| TOTAL | $630,264 | $600,352 | $517,173 | $478,353 | $592,952 |
| Non-Current Liabilities | |||||
| Long Term Debt | 371,549 | 150,000 | 150,090 | 150,359 | 624 |
| Deferred Revenues | 29,560 | 27,682 | 23,810 | 21,458 | 22,441 |
| Other Non-Current Liabilities | 31,567 | 30,638 | 31,752 | 31,236 | 28,771 |
| TOTAL | $430,897 | $229,911 | $232,899 | $233,949 | $67,391 |
| Total Liabilities | $1,061,161 | $830,263 | $750,072 | $712,302 | $660,343 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,365 | 100,540 | 102,610 | 103,200 | 103,789 |
| Common Shares | 10,170 | 10,163 | 10,155 | 10,119 | 10,081 |
| Retained earnings | 1,649,337 | 1,597,196 | 1,539,978 | 1,493,393 | 1,450,135 |
| Other shareholders' equity | 7,751 | 20,221 | 19,981 | 18,382 | 20,347 |
| TOTAL | $229,471 | $452,930 | $512,252 | $518,214 | $534,895 |
| Total Liabilities And Equity | $1,290,632 | $1,283,193 | $1,262,324 | $1,230,516 | $1,195,238 |